Literature DB >> 24225215

[Analysis of drug resistance of Acinetobacter baumannii and its related factors in ICU].

Ming-yuan Ma1, Jie Xu, Na Yu, Guo-min Huang.   

Abstract

OBJECTIVE: To investigate drug resistance of Acinetobacter baumannii and its related factors in intensive care unit (ICU), and to provide clinical basis for prevention and treatment.
METHODS: A retrospective analysis was conducted. Clinical data was collected from 1 050 patients in ICU of Foshan Hospital of Traditional Chinese Medicine from January 2011 to June 2013. The risk factors of nosocomial infection were analyzed with univariate analysis. The independent risk factor was sieved from the risk factors with P<0.05 with unconditional logistic regression analysis to analyze the related factors and drug resistance of Acinetobacter baumannii in ICU.
RESULTS: One hundred and thirteen patients suffering from nosocomial infection of Acinetobacter baumannii were found, and its incidence rate was 10.76%. There were 96 cases of infection of multi-drug resistant, extensive-drug resistant and pan-drug resistant Acinetobacter baumannii, accounting for 84.96%. Acinetobacter baumannii detection rate was 79.65% in sputum, 10.62% in urine, 4.42% in wound secretion, 3.54% in blood, and 1.77% in other drainage discharges, respectively. Univariate analysis showed that mechanical ventilation, ICU stay time≥7 days, coma [Glasgow coma score (GCS)<8], usage of broad-spectrum antibiotics were risk factors of nosocomial infection of Acinetobacter baumannii. Multivariate logistic analysis showed that the independent risk factors of nosocomial infection caused by Acinetobacter baumannii in ICU were mechanical ventilation [odds ratio (OR)= 2.957, 95%confidence interval (95%CI) 1.106-6.253, P=0.023], ICU stay time≥7 days (OR=2.991, 95%CI 1.135-6.544, P=0.022), coma (GCS<8,OR=2.894, 95%CI 1.803-7.462, P=0.010), and usage of broad-spectrum antibiotics (OR=3.054, 95%CI 1.009-6.550, P=0.004). Rate of resistance to polymyxin B was the lowest (6.19%), and it was followed by tobramycin and tigecycline, 11.50% and 28.32%, respectively.
CONCLUSIONS: Acinetobacter baumannii in ICU was conditional pathogenic bacteria with high infection rate, and the lower respiratory tract was the main site of infestation. The related factors include mechanical ventilation, ICU stay time, coma, usage of broad-spectrum antibiotics. Its antimicrobial resistance rate was high. Comprehensive measures, including environmental isolation, strict bed unit disinfection, enforcement of hand disinfection, strengthening the effort to shorten the duration of mechanical ventilation, reduction of ICU length of stay, enhancement of drainage of mucus, excretions, and other body fluids, and rational use of antibiotics should be encouraged in order to reduce Acinetobacter baumannii in ICU.

Entities:  

Mesh:

Year:  2013        PMID: 24225215     DOI: 10.3760/cma.j.issn.2095-4352.2013.11.012

Source DB:  PubMed          Journal:  Zhonghua Wei Zhong Bing Ji Jiu Yi Xue


  5 in total

1.  Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis.

Authors:  Dong Xiao; Lu Wang; Daquan Zhang; Dongming Xiang; Qi Liu; Xuezhong Xing
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

2.  Monitoring Multidrug-Resistant Acinetobacter baumannii Infections in the Neurosurgery ICU Using a Real-Time Surveillance System.

Authors:  Yuting Zhu; Mingzhu Ni; Xiaofang Fang; Tonghua Lei; Yan Sun; Reng Ding; Xiuqiong Hu; Chengxiang Bian
Journal:  Pol J Microbiol       Date:  2022-03-30

3.  Bispectral index in predicting the prognosis of patients with coma in intensive care unit.

Authors:  Lin Dou; Hong-Mei Gao; Ling Lu; Wen-Xiu Chang
Journal:  World J Emerg Med       Date:  2014

Review 4.  Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for Institutes.

Authors:  Chang-Hua Chen; Li-Chen Lin; Yu-Jun Chang; Yu-Min Chen; Chin-Yen Chang; Chieh-Chen Huang
Journal:  Int J Environ Res Public Health       Date:  2015-07-30       Impact factor: 3.390

Review 5.  Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection.

Authors:  Dan Nie; Yue Hu; Zhou Chen; Mingkai Li; Zheng Hou; Xiaoxing Luo; Xinggang Mao; Xiaoyan Xue
Journal:  J Biomed Sci       Date:  2020-01-18       Impact factor: 8.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.